Top

International Journal of Mental Health and Addiction

Published in:

01-10-2021 | Anxiety Disorder | Original Article

Likelihood of Mental Health and Substance Use Treatment Receipt among Pregnant Women in the USA

Authors: Taghreed N. Salameh, Lynne A. Hall, Timothy N. Crawford, Ruth R. Staten, Martin T. Hall

Published in: International Journal of Mental Health and Addiction | Issue 5/2021

Abstract

To explore predictors of mental health and substance use treatment receipt in pregnant women in the USA. Secondary analysis of data from the 2008–2014 National Survey on Drug Use and Health was conducted. Two logistic regression models were run to identify predictors of mental health treatment receipt among pregnant women aged 18–44 years with mental health problems (N = 1106) and predictors of substance use treatment among pregnant women with substance use disorders (N = 521). Forty four percent of pregnant women with mental health problems received mental health treatment, and only 13% of pregnant women with substance use disorders received substance use treatment. Women with anxiety disorder (vs. no disorder) (adjusted odds ratio (AOR): 17.3, 95% Confidence Interval (CI): 8.6–34.8), major depression (vs. no depression) (AOR: 2.48, 95% CI: 1.44–4.27), higher level of serious psychological distress (AOR: 1.06, 95% CI: 1.003–1.12), college (vs. less than high school) education (AOR: 2.84, 95 %CI: 1.36–5.91), and health insurance coverage (vs. no coverage) (AOR: 2.34, 95% CI: 1.16–4.71) had higher odds of mental health treatment receipt. African American (AOR: .38, 95% CI: .20–.74) and Hispanic women (AOR: .17, 95% CI: .05–.59) had lower odds for mental health treatment relative to Whites. The best set of predictors of substance use treatment receipt included NonWhite (vs. White ethnicity) (AOR: .39, 95% CI: .19–.80), large (vs. small urban) residency (AOR: 4.38, 95% CI: 1.84–10.45), alcohol and illicit drug use disorders (vs. no disorder) (AOR: 2.92, 95% CI: 1.48–5.78; AOR: 8.70, 95% CI: 3.32–22.76; respectively), and comorbid anxiety/depression disorder (vs. no disorder) (AOR: 3.13, 95% CI: 1.40–7.02). The common barriers reported by pregnant women who perceived unmet need for mental health treatment included perceived cost, opposition to treatment, and stigma, regardless of their disorder. The majority of pregnant with mental health/substance use disorders do not receive treatment. More policy and treatment initiatives that address barriers to and predictors of treatment receipt are needed to help this vulnerable population of pregnant women to gain access to mental health and substance use treatment.

Agency for Healthcare Research and Quality. (2016). Screening for depression. Retrieved from http://www.ahrq.gov/professionals/prevention-chronic-care/healthier-pregnancy/preventive/depression.html. Accessed 15 May 2017.

American College of Obstetricians and Gynecologists. (2015). Screening for perinatal depression. Retrieved from https://www.acog.org/-/media/Committee-Opinions/Committee-on-Obstetric-ractice/co630.pdf?dmc=1&ts=20160630T1521017957. Accessed 15 May 2017.

American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders: DSM IV (4th ed.). Washington, DC: Author.

Andersen, R. M. (1995). Revisiting the behavioral model and access to medical care: does it matter? Journal of Health and Social Behavior, 36(1), 1–10.CrossRef

Battle, C. L., Salisbury, A. L., Schofield, C. A., & Ortiz-Hernandez, S. (2013). Perinatal antidepressant use: understanding women's preferences and concerns. Journal of Psychiatric Practice, 19(6), 443–453. https://doi.org/10.1097/01.pra.0000438183.74359.46.CrossRefPubMedPubMedCentral

Brigham, G., Winhusen, T., Lewis, D., & Kropp, F. (2010). Incentives for retention of pregnant substance users: a secondary analysis. Journal of Substance Abuse Treatment, 38(1), 90–95. https://doi.org/10.1016/j.jsat.2009.05.005.CrossRefPubMed

Bursac, Z., Gauss, C. H., Williams, D. K., & Hosmer, D. W. (2008). Purposeful selection of variables in logistic regression. Source Code for Biology and Medicine, 3(1), 17.CrossRef

Byatt, N., Biebel, K., Debordes-Jackson, G., Lundquist, R. S., Simas, T. A. M., Weinreb, L., & Ziedonis, D. (2013). Community mental health provider reluctance to provide pharmacotherapy may be a barrier to addressing perinatal depression: a preliminary study. Psychiatric Quarterly, 84(2), 169–174.CrossRef

Byatt, N., Xiao, R. S., Dinh, K. H., & Waring, M. E. (2016). Mental health care use in relation to depressive symptoms among pregnant women in the USA. Archives of Women's Mental Health, 19(1), 187–191.CrossRef

Center for Behavioral Health Statistics and Quality. (2015). 2014 National Survey on drug use and health: methodological summary and definitions. Rockville: Substance Abuse and Mental Health Services Administration.

Center for Substance Abuse Treatment. (2009). Substance abuse treatment: addressing the specific needs of women. Retrieved from http://store.samhsa.gov/shin/content//SMA15-4426/SMA15-4426.pdf. Accessed 22 May 2017.

Chang, J. J., Tabet, M., Elder, K., Kiel, D. W., & Flick, L. H. (2016). Racial/ethnic differences in the correlates of mental health services use among pregnant women with depressive symptoms. Maternal and Child Health Journal, 20(9), 1911–1922. https://doi.org/10.1007/s10995-016-2005-1.CrossRefPubMed

Coleman-Cowger, V. H. (2012). Mental health treatment need among pregnant and postpartum women/girls entering substance abuse treatment. Psychology of Addictive Behaviors, 26(2), 345–350. https://doi.org/10.1037/a0025355.CrossRefPubMed

Connelly, C. D., Hazen, A. L., Baker-Ericzen, M. J., Landsverk, J., & Horwitz, S. M. (2013). Is screening for depression in the perinatal period enough? The co-occurrence of depression, substance abuse, and intimate partner violence in culturally diverse pregnant women. Journal of Women's Health, 22(10), 844–852. https://doi.org/10.1089/jwh.2012.4121.CrossRefPubMedPubMedCentral

Cook, C. A., Flick, L. H., Homan, S. M., Campbell, C., McSweeney, M., & Gallagher, M. E. (2010). Psychiatric disorders and treatment in low-income pregnant women. Journal of Women's Health (Larchmt), 19(7), 1251–1262. https://doi.org/10.1089/jwh.2009.1854.CrossRef

Csaszar, E., Melichercikova, K., & Dubovicky, M. (2014). Neuroendocrine and behavioral consequences of untreated and treated depression in pregnancy and lactation. Neuro Endocrinology Letters, 35(2), 169–174.PubMed

Fairbrother, N., Young, A. H., Janssen, P., Antony, M. M., & Tucker, E. (2015). Depression and anxiety during the perinatal period. BioMed Central Psychiatry, 15(1), 206.CrossRef

Fairbrother, N., Janssen, P., Antony, M. M., Tucker, E., & Young, A. H. (2016). Perinatal anxiety disorder prevalence and incidence. Journal of Affective Disorders, 200, 148–155.CrossRef

Flynn, H. A., Blow, F. C., & Marcus, S. M. (2006). Rates and predictors of depression treatment among pregnant women in hospital-affiliated obstetrics practices. General Hospital Psychiatry, 28(4), 289–295. https://doi.org/10.1016/j.genhosppsych.2006.04.002.CrossRefPubMed

Fortney, J., & Booth, B. M. (2001). Access to substance abuse services in rural areas. Recent Developments in Alcoholism, 15, 177–197.PubMed

Geier, M. L., Hills, N., Gonzales, M., Tum, K., & Finley, P. R. (2015). Detection and treatment rates for perinatal depression in a state Medicaid population. CNS Spectrums, 20(1), 11–19. https://doi.org/10.1017/s1092852914000510.CrossRefPubMed

Glasheen, C., Colpe, L., Hoffman, V., & Warren, L. K. (2015). Prevalence of serious psychological distress and mental health treatment in a national sample of pregnant and postpartum women. Maternal and Child Health Journal, 19(1), 204–216. https://doi.org/10.1007/s10995-014-1511-2.CrossRefPubMed

Goodman, J. H. (2009). Women's attitudes, preferences, and perceived barriers to treatment for perinatal depression. Birth, 36(1), 60–69. https://doi.org/10.1111/j.1523-536X.2008.00296.x.CrossRefPubMed

Goodman, J. H., & Tyer-Viola, L. (2010). Detection, treatment, and referral of perinatal depression and anxiety by obstetrical providers. Journal of Women's Health (Larchmt), 19(3), 477–490. https://doi.org/10.1089/jwh.2008.1352.CrossRef

Goodman, J. H., Chenausky, K. L., & Freeman, M. P. (2014). Anxiety disorders during pregnancy: a systematic review. Journal of Clinical Psychiatry, 75(10), e1153–e1184. https://doi.org/10.4088/JCP.14r09035.CrossRef

Grigoriadis, S., VonderPorten, E. H., Mamisashvili, L., Tomlinson, G., Dennis, C. L., Koren, G., et al. (2013). The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. Journal of Clinical Psychiatry, 74(4), e321–e341. https://doi.org/10.4088/JCP.12r07968.CrossRef

Haller, D. L., Miles, D. R., & Dawson, K. S. (2003). Factors influencing treatment enrollment by pregnant substance abusers. American Journal of Drug and Alcohol Abuse, 29(1), 117–131.CrossRef

Heil, S. H., Sigmon, S. C., Jones, H. E., & Wagner, M. (2008). Comparison of characteristics of opioid-using pregnant women in rural and urban settings. American Journal of Drug and Alcohol Abuse, 34(4), 463–471. https://doi.org/10.1080/00952990802122358.CrossRef

Homish, G. G., Cornelius, J. R., Richardson, G. A., & Day, N. L. (2004). Antenatal risk factors associated with postpartum comorbid alcohol use and depressive symptomatology. Alcoholism, Clinical and Experimental Research, 28(8), 1242–1248.CrossRef

Jaaskelainen, M., Holmila, M., Notkola, I. L., & Raitasalo, K. (2016). Mental disorders and harmful substance use in children of substance abusing parents: a longitudinal register-based study on a complete birth cohort born in 1991. Drug and Alcohol Review, 35(6), 728–740. https://doi.org/10.1111/dar.12417.CrossRefPubMed

Jackson, A., & Shannon, L. (2012). Examining barriers to and motivations for substance abuse treatment among pregnant women: does urban-rural residence matter? Women & Health, 52(6), 570–586. https://doi.org/10.1080/03630242.2012.699508.CrossRef

Jesse, D. E., Dolbier, C. L., & Blanchard, A. (2008). Barriers to seeking help and treatment suggestions for prenatal depressive symptoms: focus groups with rural low-income women. Issues in Mental Health Nursing, 29(1), 3–19. https://doi.org/10.1080/01612840701748664.CrossRefPubMed

Kessler, R. C., Barker, P. R., Colpe, L. J., Epstein, J. F., Gfroerer, J. C., Hiripi, E., Howes, M. J., Normand, S. L., Manderscheid, R. W., Walters, E. E., & Zaslavsky, A. M. (2003). Screening for serious mental illness in the general population. Archives of General Psychiatry, 60(2), 184–189.CrossRef

Kim, J. J., La Porte, L. M., Corcoran, M., Magasi, S., Batza, J., & Silver, R. K. (2010). Barriers to mental health treatment among obstetric patients at risk for depression. American Journal of Obstetrics and Gynecology, 202(3), 312.e311–312.e315. https://doi.org/10.1016/j.ajog.2010.01.004.CrossRef

Kissin, W. B., Svikis, D. S., Moylan, P., Haug, N. A., & Stitzer, M. L. (2004). Identifying pregnant women at risk for early attrition from substance abuse treatment. Journal of Substance Abuse Treatment, 27(1), 31–38. https://doi.org/10.1016/j.jsat.2004.03.007.CrossRefPubMed

Ko, J. Y., Farr, S. L., Dietz, P. M., & Robbins, C. L. (2012). Depression and treatment among US pregnant and nonpregnant women of reproductive age, 2005–2009. Journal of Women's Health, 21(8), 830–836.CrossRef

Kopelman, R. C., Moel, J., Mertens, C., Stuart, S., Arndt, S., & O'Hara, M. W. (2008). Barriers to care for antenatal depression. Psychiatric Services, 59(4), 429–432. https://doi.org/10.1176/ps.2008.59.4.429.CrossRefPubMed

Le Strat, Y., Dubertret, C., & Le Foll, B. (2011). Prevalence and correlates of major depressive episode in pregnant and postpartum women in the United States. Journal of Affective Disorders, 135(1–3), 128–138. https://doi.org/10.1016/j.jad.2011.07.004.CrossRefPubMed

Marais, S., Jordaan, E., Viljoen, D., Olivier, L., de Waal, J., & Poole, C. (2011). The effect of brief interventions on the drinking behavior of pregnant women in a high-risk rural south African community: a cluster randomized trial. Early Child Development and Care, 181(4), 463–474.CrossRef

McCabe, J. E., & Arndt, S. (2012). Demographic and substance abuse trends among pregnant and non-pregnant women: eleven years of treatment admission data. Maternal and Child Health Journal, 16(8), 1696–1702. https://doi.org/10.1007/s10995-011-0872-z.CrossRefPubMed

Melville, J. L., Gavin, A., Guo, Y., Fan, M.-Y., & Katon, W. J. (2010). Depressive disorders during pregnancy: prevalence and risk factors in a large urban sample. Obstetrics and Gynecology, 116(5), 1064–1070.CrossRef

Messer, K., Clark, K. A., & Martin, S. L. (1996). Characteristics associated with pregnant women's utilization of substance abuse treatment services. American Journal of Drug and Alcohol Abuse, 22(3), 403–422.CrossRef

O'Mahen, H. A., Henshaw, E., Jones, J. M., & Flynn, H. A. (2011). Stigma and depression during pregnancy: does race matter? Journal of Nervous and Mental Disease, 199(4), 257–262. https://doi.org/10.1097/NMD.0b013e3182125b82.CrossRef

Ondersma, S. J., Winhusen, T., & Lewis, D. F. (2010). External pressure, motivation, and treatment outcome among pregnant substance-using women. Drug and Alcohol Dependence, 107(2–3), 149–153. https://doi.org/10.1016/j.drugalcdep.2009.10.004.CrossRefPubMed

Prindle, J. J., Hammond, I., & Putnam-Hornstein, E. (2018). Prenatal substance exposure diagnosed at birth and infant involvement with child protective services. Child Abuse & Neglect, 76, 75–83.CrossRef

Rade, C. B., Desmarais, S. L., Van Dorn, R. A., Lutnick, A., Kral, A. H., & Lorvick, J. (2015). Mental health correlates of drug treatment among women who use methamphetamine. American Journal on Addictions, 24(7), 646–653. https://doi.org/10.1111/ajad.12279.CrossRef

Rosen, D., Tolman, R. M., & Warner, L. A. (2004). Low-income women's use of substance abuse and mental health services. Journal of Health Care for the Poor and Underserved, 15(2), 206–219.CrossRef

Rossen, L., Hutchinson, D., Wilson, J., Burns, L., Olsson, A. C., Allsop, S., & Mattick, R. P. (2016). Predictors of postnatal mother-infant bonding: the role of antenatal bonding, maternal substance use and mental health. Archives of Women's Mental Health, 19(4), 609–622. https://doi.org/10.1007/s00737-016-0602-z.CrossRefPubMed

Smith, D. K., Johnson, A. B., Pears, K. C., Fisher, P. A., & DeGarmo, D. S. (2007). Child maltreatment and foster care: unpacking the effects of prenatal and postnatal parental substance use. Child Maltreatment, 12(2), 150–160.CrossRef

Smith, M. V., Shao, L., Howell, H., Wang, H., Poschman, K., & Yonkers, K. A. (2009). Success of mental health referral among pregnant and postpartum women with psychiatric distress. General Hospital Psychiatry, 31(2), 155–162. https://doi.org/10.1016/j.genhosppsych.2008.10.002.CrossRefPubMed

Song, D., Sands, R. G., & Wong, Y. L. (2004). Utilization of mental health services by low-income pregnant and postpartum women on medical assistance. Women's Health, 39(1), 1–24. https://doi.org/10.1300/J013v39n01_01.CrossRef

Substance Abuse and Mental Health Services Administration. (2014a). Results from the 2013 National Survey on Drug Use and Health: summary of national findings. Retrieved from http://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf. Accessed 15 May 2017.

Substance Abuse and Mental Health Services Administration. (2014b). SAMHSA’s concept of trauma and guidance for a trauma-informed approach. Retrieved from http://store.samhsa.gov/shin/content/SMA14-4884/SMA14-4884.pdf. Accessed 15 May 2017.

Terplan, M., Smith, E. J., Kozloski, M. J., & Pollack, H. A. (2010). "Compassionate coercion": factors associated with court-mandated drug and alcohol treatment in pregnancy 1994-2005. Journal of Addiction Medicine, 4(3), 147–152. https://doi.org/10.1097/ADM.0b013e3181b562dc.CrossRefPubMed

Terplan, M., McNamara, E. J., & Chisolm, M. S. (2012). Pregnant and non-pregnant women with substance use disorders: the gap between treatment need and receipt. Journal of Addictive Diseases, 31(4), 342–349. https://doi.org/10.1080/10550887.2012.735566.CrossRefPubMed

United States Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (2015). 2014 National Survey on drug use and health: public use file codebook. Rockville: Substance Abuse and Mental Health Services Administration.

Vesga-Lopez, O., Blanco, C., Keyes, K., Olfson, M., Grant, B. F., & Hasin, D. S. (2008). Psychiatric disorders in pregnant and postpartum women in the United States. Archives of General Psychiatry, 65(7), 805–815. https://doi.org/10.1001/archpsyc.65.7.805.CrossRefPubMedPubMedCentral

Walton-Moss, B., & McCaul, M. E. (2006). Factors associated with lifetime history of drug treatment among substance dependent women. Addictive Behaviors, 31(2), 246–253. https://doi.org/10.1016/j.addbeh.2005.05.006.CrossRefPubMed

Weinreb, L., Byatt, N., Moore Simas, T. A., Tenner, K., & Savageau, J. A. (2014). What happens to mental health treatment during pregnancy? Women's experience with prescribing providers. Psychiatric Quarterly, 85(3), 349–355. https://doi.org/10.1007/s11126-014-9293-7.CrossRef

Title: Likelihood of Mental Health and Substance Use Treatment Receipt among Pregnant Women in the USA
Authors: Taghreed N. Salameh
Lynne A. Hall
Timothy N. Crawford
Ruth R. Staten
Martin T. Hall
Publication date: 01-10-2021
Publisher: Springer US
Keyword: Anxiety Disorder
Published in: International Journal of Mental Health and Addiction / Issue 5/2021
Print ISSN: 1557-1874
Electronic ISSN: 1557-1882
DOI: https://doi.org/10.1007/s11469-020-00247-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Likelihood of Mental Health and Substance Use Treatment Receipt among Pregnant Women in the USA

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2021

Psychopathological Consequences Related to Problematic Instagram Use Among Adolescents: The Mediating Role of Body Image Dissatisfaction and Moderating Role of Gender

Psychology Student Attitudes and Beliefs Toward Cannabis for Mental Health Purposes: a Cross National Comparison

Psychometric Properties of a Brief Metamemory and Metaconcentration Scale in Substance Use Problem

Borderline Personality Features and Impeded Personal Growth Initiative: the Importance of Dispositional Optimism

A Qualitative Study of caregiver’s Perceptions and Needs Around Adolescent Substance Use and Other Risk Behaviours

Measurement, Profiles, Prevalence, and Psychological Risk Factors of Problematic Gaming Among the Turkish Community: A Large-scale National Study